Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CDC25B | P30305 | 1/20 | 0.50 |
| ▸ | CASP6 | P55212 | 1/20 | 0.50 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.50 |
| ▸ | GFER | P55789 | 1/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | APEX1 | P27695 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23319841 | 0.84 | ALDH1A1 (0.58) | KMT2AKDM4EALDH1A1MEN1MAPT | |
| SCHEMBL10979724 | 0.83 | ALDH1A1 (0.49) | KMT2AKDM4EALDH1A1CDC25BCASP6 | |
| SCHEMBL10984175 | 0.83 | NPSR1 (0.48) | KMT2AKDM4EALDH1A1CDC25BCASP6 | |
| SCHEMBL29505008 | 0.82 | LMNA (0.44) | KMT2AKDM4EALDH1A1MEN1MAPT | |
| SCHEMBL22719745 | 0.82 | LMNA (0.44) | KMT2AKDM4EALDH1A1MEN1MAPT | |
| SCHEMBL2825786 | 0.81 | ALDH1A1 (0.62) | KMT2AKDM4EALDH1A1CASP6POLB | |
| SCHEMBL19119211 | 0.81 | POLB (0.59) | KMT2AKDM4EALDH1A1POLBMEN1 | |
| SCHEMBL2512589 | 0.81 | LMNA (0.64) | KMT2AKDM4EALDH1A1CDC25BCASP6 | |
| SCHEMBL28650672 | 0.81 | CA2 (0.49) | KMT2AKDM4EALDH1A1POLBMEN1 | |
| SCHEMBL11092515 | 0.81 | ALDH1A1 (0.56) | KMT2AKDM4EALDH1A1CASP6POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4505913-A | Substituted anthranilamides and pharmaceutical preparations containing these compounds | CIBA-GEIGY CORPORATION (US) | 1985-03-19 | — | — | US | claimed |
| EP-0008072-B1 | SUBSTITUTED ANTHRANILIC ACID AMIDES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PREPARATION | CIBA-GEIGY AG (CH) | 1984-02-22 | — | — | EP | claimed |
| US-7326288-B2 | Trisazo compound, ink composition, and colored object | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2008-02-05 | — | — | US | disclosed |
| US-20070107628-A1 | Trisazo compound, ink composition, and colored object | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2007-05-17 | — | — | US | disclosed |
| CN-1886467-A | Trisazo compound, ink composition, and colored body | NIPPON KAYAKU KK (JP) | 2006-12-27 | — | — | CN | disclosed |
| EP-1693422-A1 | TRISAZO COMPOUND, INK COMPOSITION, AND COLORED OBJECT | Nippon Kayaku Kabushiki Kaisha (JP) | 2006-08-23 | — | — | EP | disclosed |
| EP-0374815-B1 | Complex copper formazane compounds, process for their preparation and their use as dyestuffs | HOECHST AG (DE) | 1994-05-04 | — | — | EP | disclosed |
| US-5028700-A | For cotton, wool, polyamide, red, violet | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-07-02 | — | — | US | disclosed |
| EP-0374815-A1 | Complex copper formazane compounds, process for their preparation and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-06-27 | — | — | EP | disclosed |
| US-4505913-A | Substituted anthranilamides and pharmaceutical preparations containing these compounds | CIBA-GEIGY CORPORATION (US) | 1985-03-19 | — | — | US | disclosed |
| EP-0008072-B1 | SUBSTITUTED ANTHRANILIC ACID AMIDES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PREPARATION | CIBA-GEIGY AG (CH) | 1984-02-22 | — | — | EP | disclosed |
| EP-0008072-A1 | Substituted anthranilic acid amides, process for their preparation, pharmaceutical compositions containing them and their preparation | CIBA-GEIGY AG (CH) | 1980-02-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070107628-A1 | Trisazo compound, ink composition, and colored object | UFL1, TMT1A, JAK1 | KMT2A 588/4885KDM4E 848/4885ALDH1A1 1635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.